Master Angiotensin Receptor Blockers (ARBs) with Picmonic for Medicine

These drugs are effective hypertension treatments, especially when patients are not tolerant of ACE inhibitor therapy. They block angiotensin II AT1 receptors, leading to vasopressin and aldosterone reduction, reducing blood pressure.

These drugs may be used to treat CHF in patients intolerant to therapy with ACE inhibitors, particularly candesartan.

These drugs have used to treat kidney damage from diabetes type II and may delay the progression of disease.

These drugs block the activation of angiotensin II AT1 receptors, without affecting bradykinin levels. This results in vasodilation, and reduction of vasopressin secretion and reduction of aldosterone production and secretion.

Hyperkalemia is a rare adverse effect of angiotensin receptor blockers, as it may interfere with normal urinary excretion. Patients with high potassium levels should be cautioned with this medication.

ARBs are not major human teratogens, but are generally avoided in all trimesters of pregnancy due to the risk of adverse effects. While more recent research has concluded that the use of ARBS is generally unsafe in only the 2nd and 3rd trimesters other research has shown complications in the 1st trimester. It is generally recommended to avoid ARBs in pregnant patients since there are many other safe alternatives.